60 related articles for article (PubMed ID: 1944190)
1. [Clinical significance of immunotherapy for lung cancer--present and future].
Watanabe Y; Shimizu J; Oda M; Yoshida M; Watanabe S; Iwa T
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1217-20. PubMed ID: 1944190
[TBL] [Abstract][Full Text] [Related]
2. [Surgery and adjuvant therapy of non-small cell lung cancer].
Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy for lung cancer by streptococcal preparation OK-432].
Watanabe Y; Shimizu J; Yoshida Y; Hashizume Y; Yamada T; Iwa T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1432-5. PubMed ID: 2586434
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
Watanabe Y; Iwa T
J Biol Response Mod; 1987 Apr; 6(2):169-80. PubMed ID: 3585412
[TBL] [Abstract][Full Text] [Related]
5. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
Kimura H; Yamaguchi Y
Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
7. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Fujisawa T; Yamaguchi Y
Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.
Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y;
J Immunother; 2001; 24(3):250-6. PubMed ID: 11394503
[TBL] [Abstract][Full Text] [Related]
9. [Immunochemotherapy of resectable lung cancer--a preliminary study on a comparison of the control, levamisole, and OK-432].
Okayasu T; Kashimura Y; Matano J; Kawabata M; Takeoka T; Hashimoto M; Tanabe T
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1646-52. PubMed ID: 6764120
[TBL] [Abstract][Full Text] [Related]
10. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.
Yamamura Y; Ogura T; Sakatani M; Hirao F; Kishimoto S; Fukuoka M; Takada M; Kawahara M; Furuse K; Kuwahara O
Cancer Res; 1983 Nov; 43(11):5575-9. PubMed ID: 6616485
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
[TBL] [Abstract][Full Text] [Related]
15. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
[TBL] [Abstract][Full Text] [Related]
17. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy].
Watanabe Y
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413
[TBL] [Abstract][Full Text] [Related]
18. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
Fujisawa T; Yamaguchi Y
Cancer; 1996 Nov; 78(9):1892-8. PubMed ID: 8909308
[TBL] [Abstract][Full Text] [Related]
19. Final report of a randomized controlled study with streptococcal preparation OK-432 as a supplementary immunopotentiator for laryngeal cancer.
Kimura T; Suzuki K; Motai H; Miyamoto N; Tsuge I; Ito Y; Baba S
Acta Otolaryngol Suppl; 1996; 525():135-41. PubMed ID: 8908288
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on the effect of adjuvant immunochemotherapy using OK-432 and 5-FU in pharyngeal and laryngeal cancers].
Yajin K; Harada Y; Tagashira N; Suzuki M; Hirakawa K; Sera K; Nakata M; Takebayashi S; Okazaki H; Yashiki T
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1921-7. PubMed ID: 3289502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
